Artificial cells in liver disease - Artificial Cells, Cell Engineering and Therapy - page 235

30. Bilir BM, Guinette D, Karrer F, Kumpe DA, Krysl J, Stephens J, McGavran L,
Ostrowska A, Durham J. Hepatocyte transplantation in acute liver failure. Liver
Transpl 2000; 6: 32±40.
31. Fisher RA, Strom SC. Human hepatocyte transplantation: biology and therapy. In:
Berry M, Edwards A (eds), The Hepatocyte Review. London: Kluwer Academic
Publishers, 2000.
32. Grossman M, Rader DJ, Muller DW, Kolansky DM, Kozarsky K, Clark BJ 3rd,
Stein EA, Lupien PJ, Brewer HB Jr, Raper SE. A pilot study of ex vivo gene therapy
for homozygous familial hypercholesterolemia. Nature Med 1995; 1: 1148±1154.
33. Chowdhury JR, Grossman M, Gupta S, Chowdhury NR, Baker JR Jr, Wilson JM.
Long term improvement of hypercholesterolemia after ex vivo gene therapy in LDL-
receptor deficient rabbits. Science 1991; 254: 1802±1805.
34. Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, Lupien PJ,
Wilson JM. Successful ex vivo gene therapy directed to the liver in a patient with
familial hypercholesterolemia. Nat Genet 1994; 6: 335±341.
35. Raper SE. Hepatocyte transplantation and gene therapy. Clin Transplant 1995; 9(3
Pt 2): 249±254.
36. Raper SE, Grossman M, Rader DJ, Thoene JG, Clark BJ 3rd, Kolansky DM, Muller
DW, Wilson JM. Safety and feasibility of liver-directed ex vivo gene therapy for
homozygous familial hypercholesterolemia. Ann Surg 1995; 223: 116±126.
37. Horslen SP, McCowan TC, Goertzen TC, Warkentin PI, Cai HB, Strom SC, Fox IJ.
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder.
Pediatrics 2003; 111(6 Pt 1): 1262±1267.
38. Strom SC, Fisher RA, Rubinstein WS, Barranger JA, Towbin RB, Charron M,
Mieles L, Pisarov LA, Dorko K, Thompson MT, Reyes J. Transplantation of human
hepatocytes. Transplant Proc 1997; 29(4): 2103±2106.
39. Muraca M, Gerunda G, Neri D, Vilei MT, Granato A, Feltracco P, Meroni M, Giron
G, Burlina AB. Hepatocyte transplantation as a treatment for glycogen storage
disease type 1a. Lancet 2002; 359(9303): 317±318.
40. Sokal EM, Smets F, Bourgois A, Van Maldergem L, Buts JP, Reding R, Bernard
Otte J, Evrard V, Latinne D, Vincent MF, Moser A, Soriano HE. Hepatocyte
transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique,
safety, and metabolic follow-up. Transplantation 2003; 76(4): 735±738.
41. Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI,
Dorko K, Sauter BV, Strom SC. Treatment of the Crigler-Najjar syndrome type I
with hepatocyte transplantation. N Engl J Med 1998; 338(20): 1422±1426.
42. Lee SW, Wang X, Chowdhury NR, Roy-Chowdhury J. Hepatocyte transplantation:
state of the art and strategies for overcoming existing hurdles. Ann Hepatol 2004; 3:
48±53.
43. Takimoto Y, Dixit V, Arthur M, Gitnick G. De novo liver tissue formation in rats
using a novel collagen-polypropylene scaffold. Cell Transplant 2003; 12(4): 413±
421.
44. Dixit V, Elcin YM. Liver tissue engineering: successes & limitations. Adv Exp Med
Biol 2003; 534: 57±67.
45. Dixit V. Transplantation of isolated hepatocytes and their role in extrahepatic life
support systems. Scand J Gastroenterol 1995; 30(208): 101±110.